Upsher-Smith

Manufactures branded generic pharmaceuticals for the ever-changing needs of pharmacists, physicians, patients and healthcare organizations. Since 1919, the Upsher-Smith name has been recognized as a hallmark of quality, value, and innovation. Today, Upsher-Smith stretches far beyond the pharmacy, from specialist physicians to pharmaceutical purchasers, from managed care to primary care. Upsher-Smith's branded generics, answer the healthcare industry's need for reliable, affordable pharmaceutical products. Some of the innovative products Upsher-Smith has introduced over the years includeKlor-Con® Tablets (Potassium Chloride Extended-release Tablets, USP), the first economically priced, branded, potassium chloride alternative, Pacerone® (Amiodarone HCl) Tablets 200 mg, the first AB Rated amiodarone HCl, AmLactin® 12% Moisturizing Lotion and Cream, the first cosmetic formulation of 12% lactic acid neutralized with ammonium hydroxide, and RMS® Suppositories CII (Rectal Morphine Sulfate), the first commercially available rectal morphine sulfate dosage form. Another of our pioneer products is SSKI® (Potassium Iodide Oral Solution, USP). Upsher-Smith was also the first U.S. pharmaceutical company to promote a line of herbal/nutraceutical products to health care professionals. Upsher-Smith currently markets Alterra™ (St. John's Wort), Provol™ (pygeum africanum), and Folgard™ (Folic acid, Vitamin B-6, Vitamin B-12, Combination).

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Cosmoceuticals
- Generics
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Phyto

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: